(Q50860489)

24 March 2018

title

Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome (English)

1 reference

24 March 2018

author name string

Wenstrom KD

1

1 reference

24 March 2018

Chu DC

2

1 reference

24 March 2018

Owen J

3

1 reference

24 March 2018

Boots L

4

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

24 March 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

24 March 2018

volume

179

1 reference

24 March 2018

issue

4

1 reference

24 March 2018

page(s)

966-970

1 reference

24 March 2018

Prenatal screening for Down's syndrome with use of maternal serum markers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Evaluation of multiple-marker screening for Down syndrome in a statewide population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Down syndrome prevention program in a population with an older maternal age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Prenatal screening for trisomy 18 in the second trimester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Detection of fetal Turner syndrome with multiple-marker screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Second-trimester dimeric inhibin-A in Down's syndrome screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Free α-subunit of human chorionic gonadotropin in Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical Markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Urinary beta-core human chorionic gonadotrophin: a new approach to Down's syndrome screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative european study on 52 965 amniocenteses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970198-X

10.1016/S0002-9378(98)70198-X

7 January 2021

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018